Basics Royalty Pharma plc IPO Date: June 16, 2020 Sector: Healthcare Industry: Biotech Market Cap: $15.83B Activated in VL: True Average Daily Range Avg Daily Range: $0.45 | 1.18% Avg Daily Range (30 D): $0.39 | 1.09% Avg Daily Range (90 D): $0.35 | 0.97% Institutional Daily Volume Avg Daily Volume: 2.06M Avg Daily Volume (30 D): 2.8M Avg Daily Volume (90 D): 2.8M Trade Size Avg Trade Size (Sh.): 93 Avg Trade Size (Sh.) (30 D): 75 Avg Trade Size (Sh.) (90 D): 78 Institutional Trades Total Inst.Trades: 8,560 Avg Inst. Trade: $4.62M Avg Inst. Trade (30 D): $10.51M Avg Inst. Trade (90 D): $6.73M Avg Inst. Trade Volume: .13M Avg Inst. Trades (Per Day): 6 Market Closing Trades Avg Closing Trade: $13.59M Avg Closing Trade (30 D): $46.69M Avg Closing Trade (90 D): $29.72M Avg Closing Volume: 384.18K     News Sep 3, 2025 @ 12:30 AM Royalty Pharma Announces Pricing of $2.0 Billion o... Source: Royalty Pharma Aug 25, 2025 @ 10:10 AM Royalty Pharma to Acquire Royalty Interest in Amge... Source: Globe Newswire Jul 18, 2025 @ 12:15 PM Royalty Pharma Declares Third Quarter 2025 Dividen... Source: Globe Newswire May 16, 2025 @ 8:30 PM Royalty Pharma Completes the Acquisition of Its Ex... Source: Globe Newswire May 12, 2025 @ 8:15 PM Royalty Pharma Announces Shareholder Approval of i... Source: Globe Newswire Financials   TTM Q2 2025 Q1 2025 Basic EPS $.07 $.55 Diluted EPS $.07 $.55 Revenue $ $ 578.67M $ 568.25M Gross Profit $ $ $ Net Income / Loss $ $ 90.64M $ 433.43M Operating Income / Loss $ $ 209.8M $ 534.18M Cost of Revenue $ $ $ Net Cash Flow $ $ -455.81M $ 158.69M PE Ratio     Splits Oct 15, 2010:   1:4